Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | VRTX | ||
| Company | Gilead Sciences Inc | Amgen Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 124.81 | 344.23 | 462.00 | ||
| High | 124.96 | 346.33 | 463.70 | ||
| Low | 122.40 | 338.94 | 453.54 | ||
| Latest | 122.62 | 340.16 | 457.36 | ||
| Change | -2.38 | -5.26 | -5.77 | ||
| % Change | -1.90% | -1.52% | -1.25% | ||
| Volume | 5,234,200 | 3,695,800 | 1,518,900 | ||
| 20-Day Average Volume | 6,931,200 | 2,905,470 | 1,434,730 | ||
| Previous Close | 125.00 | 345.42 | 463.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.46 | 336.77 | 431.02 | ||
| 20-Day Raw Stochastic | 47.45% | 81.63% | 88.65% | ||
| 20-Day Relative Strength | 50.56 | 61.86 | 64.10 | ||
| Weighted Alpha | +31.19 | +28.98 | +3.49 | ||
| Today's Opinion | 80% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.83% since 11/26/25 | -1.28% since 11/26/25 | +5.83% since 11/26/25 | ||
| Low | 122.40 on 12/04/25 | 336.25 on 12/01/25 | 423.45 on 12/01/25 | ||
| High | 127.80 on 11/28/25 | 346.38 on 12/03/25 | 463.85 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | -0.31% since 11/04/25 | +14.65% since 11/04/25 | +8.46% since 11/04/25 | ||
| Low | 117.13 on 11/10/25 | 302.13 on 11/05/25 | 406.67 on 11/07/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 463.85 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +8.73% since 09/04/25 | +21.44% since 09/04/25 | +15.22% since 09/04/25 | ||
| Low | 108.46 on 10/02/25 | 269.77 on 09/26/25 | 374.17 on 09/24/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 463.85 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +12.47% since 06/04/25 | +18.52% since 06/04/25 | +2.58% since 06/04/25 | ||
| Low | 104.46 on 06/25/25 | 267.83 on 06/23/25 | 362.50 on 08/11/25 | ||
| High | 128.70 on 11/20/25 | 346.38 on 12/03/25 | 484.56 on 07/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 152,132,192 | 183,169,696 | 116,040,920 | ||
| Shares Outstanding, K | 1,240,680 | 538,481 | 253,719 | ||
| Annual Sales | 28,754,000,000 | 33,424,000,000 | 11,020,100,000 | ||
| Annual Net Income | 480,000,000 | 4,090,000,000 | -535,600,000 | ||
| Last Quarter Sales | 7,769,000,000 | 9,557,000,000 | 3,076,400,000 | ||
| Last Quarter Net Income | 3,052,000,000 | 3,216,000,000 | 1,082,900,000 | ||
| 60-Month Beta | 0.32 | 0.45 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.47 on 10/30/25 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | ||
| Latest Earnings Date | 10/30/25 | 11/04/25 | 11/03/25 | ||
| Most Recent Dividend | 0.790 on 09/15/25 | 2.380 on 11/21/25 | N/A | ||
| Next Ex-Dividends Date | 12/15/25 | 11/21/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.26 | 15.79 | 30.25 | ||